First Autonomous Blood-Draw Robot Gets FDA Authorization
The U.S. Food and Drug Administration has given the green light to Aletta, a groundbreaking robotic system capable of performing blood draws entirely on its own...
Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India
Wockhardt Limited announced the launch of the Wockhardt Antibiotic Academy, a national initiative dedicated to fostering patient-centric scientific dialogue and advancing continuous medical education to...
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder
AstraZeneca's Alexion unit has reported divergent outcomes from its late-stage program testing Ultomiris (ravulizumab) in patients with thrombotic microangiopathy following hematopoietic stem cell transplant (HSCT-TMA), a rare and...
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received approval from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Application...
Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III
Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of Phase II Proof-of-Concept trials and approval...
